Insider · CIK 0001724974
Sharon Bowen
Files at AKAM (AKAMAI TECHNOLOGIES INC), ICE (Intercontinental Exchange, Inc.). First filing Jul 2, 2025, latest Jul 29, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ICE: Intercontinental Exchange, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 6Weak | Intercontinental Exchange, Inc. | $147k 794 shares | -5% | +30% from low0% from high | |
| 6Weak | Intercontinental Exchange, Inc. | $146k 795 shares | -5% | +28% from low-1% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 25, 2025 | ICE Intercontinental Exchange, Inc. | SOpen-market sale Common Stock10b5-1 | -794 | $185.00 | $147k | 14,206 | Jul 29, 2025 |
| Jul 1, 2025 | ICE Intercontinental Exchange, Inc. | SOpen-market sale Common Stock10b5-1 | -795 | $183.30 | $146k | 15,000 | Jul 2, 2025 |
| May 16, 2025 | ICE Intercontinental Exchange, Inc. | AGrant or award Common Stock | +1,333 | $0.00 | $0 | 15,795 | May 20, 2025 |
| May 14, 2025 | AKAM AKAMAI TECHNOLOGIES INC | AGrant or award Deferred Stock Unitsderivative | +3,547 | $0.00 | $0 | 3,547 | May 16, 2025 |
| May 12, 2025 | AKAM AKAMAI TECHNOLOGIES INC | MOption exercise Common Stock | +2,823 | - | - | 8,278 | May 12, 2025 |
| May 12, 2025 | AKAM AKAMAI TECHNOLOGIES INC | MOption exercise Deferred Stock Unitsderivative | -2,823 | $0.00 | $0 | 0 | May 12, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.